Automating the Hematology Lab: The DH-8000 and the Push for Diagnostic Throughput

DH-8000 Fully Automated Hematology Analysis Line

Hospital laboratories in China are under strain, handling rising caseloads with finite staff. One practical response is to replace discrete manual steps with a unified, automated workflow. The DH-8000 Fully Automated Hematology Analysis Line is a tier-1 example of this infrastructure upgrade.

The system integrates blood cell analysis, intelligent recheck, slide preparation, and infection marker testing for CRP, SAA, PCT, and IL-6 into a single platform. Rather than moving tubes between separate stations, the DH-8000 handles the entire cycle—reducing human error and freeing technicians for higher-judgment tasks.

Its AI-assisted analysis module flags abnormal results and graphical data automatically, accelerating the path from sample to diagnosis. For a 500-bed hospital processing hundreds of CBCs daily, that compression of time has direct operational impact.

Modular scalability also matters. Labs can configure the line to their real volumes, adding modules as testing demands grow. This reduces upfront capital risk and aligns investment with actual throughput needs.

China’s diagnostic supply chains now produce systems like the DH-8000 at a price point that makes full automation accessible to municipal and regional hospitals, not just top-tier national centers. That shift is reshaping procurement patterns across the sector.

The DH-8000 is not a breakthrough in assay biology. It is a breakthrough in process integration—and that, increasingly, is where the real efficiency gains in clinical diagnostics are found.

Why it matters:
For lab directors and hospital procurement teams, adopting an integrated hematology line means fewer manual interventions, higher throughput, and consistent slide quality. Backed by domestic manufacturing, the DH-8000 signals growing maturity in China’s automated diagnostics industry.

View Product →